Luminostics, Inc. Smartphone-Based Point-of-Care Test for Rapid SARS-CoV-2 Antigen Detection from Nasal Swabs
Award Notice Posted
- Solicitation number
- 75N92020C00029
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Luminostics Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N92020C00029 Federal contract award
- NAICS code
- Not on record
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a contract to Luminostics, Inc. for the development of a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. The contract, valued at $26.12 million, was awarded on September 30, 2020 under an emergency COVID-19 justification and will support Luminostics, Inc. in developing a test to detect the presence of SARS-CoV-2 antigens using a smartphone platform.
Notice text
This is a COVID-19 award which utilized the Class J&A for emergency contract actions.
Awarded contract 75N92020C00029 to LUMINOSTICS, INC. for 26120000.00 on 2020-09-30.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity